G protein-coupled receptors as disease targets: Emerging paradigms

Ochsner Journal

Volumn 10, Issue 1, 2010, Pages 2-7

  Cook, Julia L ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

GPCR; Nuclear receptors; Receptor cleavage; RIP (regulated intramembrane proteolysis)

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ANGIOTENSIN 1 RECEPTOR; BETA ARRESTIN; BMS 708163; CANDESARTAN; G PROTEIN COUPLED RECEPTOR; GAMMA SECRETASE INHIBITOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HYBRID PROTEIN; IRBESARTAN; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VALSARTAN;

ALZHEIMER DISEASE; ARTICLE; BINDING SITE; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; DRUG RECEPTOR BINDING; DRUG TARGETING; HUMAN; NONHUMAN; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN FAMILY; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

EID: 77954499553     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Allen RA, Jesaitis AJ, Sklar LA, Cochrane CG, Painter RG. Physicochemical properties of the N-formyl peptide receptor on human neutrophils. J Biol Chem. 1986;261(4):1854-1857.
2. Shenoy SK, Lefkowitz RJ. Multifaceted roles of b-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J. 2003;375(pt 3):503-515.
3. Hunyady L, Baukal AJ, Gaborik Z, et al. Differential PI 3-kinase dependence of early and late phases of recycling of the internalized AT1 angiotensin receptor. J Cell Biol. 2002;157(7):1211-1222.
4. Cook JL, Re RN. Intracellular accumulation and nuclear trafficking of angiotensin II and the angiotensin II type I receptor. In: Frohlich ED, Re RN, eds. The Local Cardiac Renin Angiotensin-Aldosterone System. 2nd ed. New York: Springer, 2009:29-41.
5. Carpenter G. Nuclear localization and possible functions of receptor tyrosine kinases. Curr Opin Cell Biol. 2003;15(2):143- 148.
6. Ehrmann M, Clausen T. Proteolysis as a regulatory mechanism. Annu Rev Genet. 2004;38:709-724.
7. Wells A, Marti U. Signalling shortcuts: cell-surface receptors in the nucleus? Nat Rev Mol Cell Biol. 2002;3(9):697-702.
8. McElhinny AS, Li JL, Wu L. Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways. Oncogene. 2008;27(38):5138-5147.
9. Sisodia SS, Gallagher M. A role for the b-amyloid precursor protein in memory? Proc Natl Acad Sci U S A. 1998;95(21):12074- 12076.
10. Anderson JJ, Holtz G, Baskin PP, et al. Reductions in b-amyloid concentrations in vivo by the c-secretase inhibitors BMS-289948 and BMS-299897. Biochem Pharmacol. 2005;69(4):689- 698.
11. Raychaudhuri M, Mukhopadhyay D. AICD and its adaptors: in search of new players. J Alzheimers Dis. 2007;11(3):343- 358.
12. Lee DK, Lança AJ, Cheng R, et al. Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem. 2004;279(9):7901-7908.
13. Gobeil F, Fortier A, Zhu T, et al. G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm. Can J Physiol Pharmacol. 2006;84(3-4):287-297.
14. Cook JL, Mills SJ, Naquin RT, Alam J, Re RN. Cleavage of the angiotensin II type 1 receptor and nuclear accumulation of the cytoplasmic carboxy-terminal fragment. Am J Physiol Cell Physiol. 2007;292(4):C1313-C1322.
15. Re RN. Implications of intracrine hormone action for physiology and medicine. Am J Physiol Heart Circ Physiol. 2003;284(3):H751-H757.
16. Re RN, Cook JL. The intracrine hypothesis: an update. Regul Pept. 2006;133(1-3):1-9.
17. Mathew D, Ataman B, Chen J, Zhang Y, Cumberledge S, Budnik V. Wingless signaling at synapses is through cleavage and nuclear import of receptor DFrizzled2. Science. 2005;310(5752):1344-1347.
18. Wu W, Lin F, Worman HJ. Intracellular trafficking of MAN1, an integral protein of the nuclear envelope inner membrane. J Cell Sci. 2002;115(pt 7):1361-1371.
19. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International Union of Pharmacology, XXIII: the angiotensin II receptors. Pharmacol Rev. 2000;52(3):415-472.
20. Nikiforovich GV, Marshall GR. 3D model for TM region of the AT-1 receptor in complex with angiotensin II independently validated by site-directed mutagenesis data. Biochem Biophys Res Commun. 2001;286(5):1204-1211.
21. Noda K, Saad Y, Karnik SS. Interaction of Phe8 of angiotensin II with Lys199 and His256 of AT1 receptor in agonist activation. J Biol Chem. 1995;270(48):28511-28514.